Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort Study

References

• Bearman, S.I. (1995). The syndrome of hepatic veno-occlusive disease after marrow transplantation, Blood, 85, 3005–3020.
   PubMed Web of Science ®Google Scholar
• McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M. and Clift, R. A. (1993). Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients, Annals of Internal Medicine, 118, 255–267.
   PubMed Web of Science ®Google Scholar
• Shulman, H. M. and Hinterberger, W. (1992). Hepatic veno-oclusive disease-liver toxicity syndrome after bone marrow transplantation, Bone Marrow Transplantation, 10, 197–214.
   PubMed Web of Science ®Google Scholar
• Rozman, C., Carreras, E., Qian, C., Gale, R.P., Bortin, M. M., Rowlings, P. A., Ash, R. C., Champlin, R. E., Henslee-Downey, P.J., Herzig, R. H., Hinterberger, W., Klein, J. P., Prentice, H. G., Reiffers, J., Zwaan, F. E. and Horowitz, M. M. (1996). Risk factors for hepatic veno-occlusive disease following HLA-identical sibiling bone marrow transplants for leukemia, Bone Marrow Transplant., 17, 75–80.
   PubMed Web of Science ®Google Scholar
• Baglin, T. P. (1994). Veno-occlusive disease of the liver complicating bone marrow transplantation, Bone Marrow Transplant., 13, 1–4.
   PubMed Web of Science ®Google Scholar
• Mc Kay, P.J., Murphy, J. A., Cameron, S., Burnett, A. K., Campbell, M., Tansey, P. and Franklin, I. M. (1996). Iron overload and liver dysfunction after allogenic or autologous bone marrow transplantation, Bone Marrow Transplant., 17, 63–66.
   PubMed Web of Science ®Google Scholar
• Or, R., Matzner, Y. and Konijn, A. M. (1987). Serum ferritin in patients undergoing bone marrow transplantation, Cancer, 60, 1127–1131.
   PubMed Web of Science ®Google Scholar
• Marx, J. J. M. and van Asbeck, B. S. (1996). Use of iron chelators in preventing hydroxyl radical damage: adult respiratory distress syndrome as an experimental model for the pathophysiology and treatment of oxygenradical-mediated tissue damage, Acta Haematologica, 65, 49–62.
   Google Scholar
• Hernandez-Navarro, F., Ojeda, E., Arrieta, R., Garcia-Bustos, J., Rios-Rull, P., Quevedo, E., Camara, C., Garcia de Miguel, P., Martinez, A., Gonzalez-Baron, M., Zamora, P., Pastrana, G. and Calero, F. (1995). Singlecentre experience of peripheral blood stem cell transplantation using cryopreservation by immersion in a methanol bath, Bone Marrow Transplant., 16, 71–77.
   PubMed Web of Science ®Google Scholar
• Antman, K., Ayash, L., Elias, A., Wheeler, C., Hunt, M., Eder, J. P., Teicher, B. A., Critchlow, J., Bibbo, J., Schnipper, L. E. and Frei III, E. (1992). A phase II study of High-dose cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow support in women with measurable advanced breast cancer responding to standard-dose therapy, J. Clin. Oncol., 10, 102–110.
   PubMed Web of Science ®Google Scholar
• McMillan, A. K. and Goldstone, A. H. (1991). Autologous bone marrow transplantation for non-Hodgkin's lymphoma, Eur. J. Hematol., 46, 129–135.
   PubMed Web of Science ®Google Scholar
• Tutschka, P. J., Copelan, E. A. and Klein, J. P. (1987). Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen, Blood, 70, 1382–1388.
   PubMed Web of Science ®Google Scholar
• Aguado, M. J., Hernandez-Navarro, F., Bello, J. L., Ojeda, E., Garcia-Bustos, J. and Arrieta, R. (1998). Autotransplantation in Chronic Myeloid Leukemia, Bone Marrow Transplant., 22, 831.
   PubMed Web of Science ®Google Scholar
• Mc Donald, G. B., Sharma, P., Matthews, D. E., Shulman, H. M. and Thomas, E. D. (1984). Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence and predisposing factors, Hepatology, 4, 116–122.
   PubMed Web of Science ®Google Scholar
• Lassau, N., Leclere, J., Auperin, A., Bourhis, J. H., Hartmann, O., Valteau-Couanet, D., Benhamou, E., Bosq, J., Ibrahim, A., Girinski, T., Pico, J. L. and Roche, A. (1997). Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: Value of grayscale and Doppler US in 100 patients, Radiology, 204, 545–552.
   PubMed Web of Science ®Google Scholar
• Méresse, V., Hartmann, O., Vassal, G., Benhamou, E., Valteau-Couanet, D., Brugieres, L. and Lemerle, J. (1992). Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimenes followed by autologous bone marrow transplantation: a study in 136 children, Bone Marrow Transplant., 10, 135–141.
   PubMed Web of Science ®Google Scholar
• Jones, R. J., Lee, K. S. K., Beschorner, W. E., Vogel, V. G., Grochow, L. B., Braine, H. G., Vogelsang, G. B., Sensenbrenner, L. L., Santos, G. W. and Saral, R. (1987). Venoocclusive disease of the liver following bone marrow transplantation, Transplantation, 44, 778–783.
   PubMed Web of Science ®Google Scholar
• Kami, M., Mori, S., Tanikawa, S., Akiyama, H., Onozawa, Y., Tanaka, T., Okamoto, R., Maeda, Y., Sasaki, T., Kaku, H., Matsuura, Y., Hiruma, K. and Sakamaki, H. (1997). Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution, Bone Marrow Transplant., 20, 397–402.
   PubMed Web of Science ®Google Scholar
• Mc Donald, G. B., Schulman, H. M., Wolford, J. L. and Spencer, G. D. (1987). Liver disease after bone marrow transplantation, Seminars in Liver Disease, 7, 210–227.
   PubMed Web of Science ®Google Scholar
• Park, Y.-D., Yasui, M., Yoshimoto, T., Chayama, K., Shimono, T., Okamura, T., Inoue, M., Yumura-Yagi, K. and Kawa-Ha, K. (1997). Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation, Bone Marrow Transplant., 19, 915–920.
   PubMed Web of Science ®Google Scholar